Dermatologicals in the United Kingdom

Dermatologicals in the United Kingdom

Hair loss treatments remains the most dynamic performer within dermatologicals in the UK, recording 38% current value growth and 34% retail volume growth in the first half of 2024. As with many consumer health categories, the growth is mainly being driven by greater understanding of active ingredients and the benefits they can have for consumers. Minoxidil, as a treatment for hair loss in both men and women, is a widely discussed topic on social media in 2024, and the open discussion has made ha...

Euromonitor International's Dermatologicals in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.